Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease
Authors:
- Wai-Man WongWWWai-Man Wong
- Wai-Hong ChenWCWai-Hong Chen
- Hung-Fat TseHTHung-Fat Tse
- Pui-Yin LeePLPui-Yin Lee
- Kam-Chuen LaiKLKam-Chuen Lai
- Sheung-Wai LiSLSheung-Wai Li
- Matthew NgMNMatthew Ng
- Kwok-Fai LamKLKwok-Fai Lam
- Xi ChengXCXi Cheng
- Chu-Pak LauCLChu-Pak Lau
Open Access
- 1 January 2006
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 12 (18) , 2923-2927
Abstract
AIM: The use of low-dose aspirin to prevent cardiovascular disease events is well established. However, the incidence and predictors of upper gastrointestinal bleeding (UGIB) with its use are unknown. We studied prospectively the incidence and outcome of peptic ulceration in low-dose aspirin users. METHODS: A total of 991 patients with coronary artery disease (CAD) on low-dose aspirin were prospectively followed-up for two years for the occurrence and clinical features of first hospitalized episode of UGIB. RESULTS: UGIB had a bimodal presentation with 45% occurring within four months of aspirin initiation and had an overall prevalence of 1.5% per year. There was no UGIB-related death. Hypertension (OR = 4.6, 95%CI 1.5 - 14.7, P = 0.009), history of peptic ulceration (OR = 3.1, 95%CI 1.1 - 9.0, P = 0.039), tertiary education (OR = 3.08, 95%CI 1.1 - 9.0, P = 0.039) and higher lean body mass (P = 0.016) were independent factors associated with UGIB. Use of nitrate did not reduce UGIB. CONCLUSION: The incidence of UGIB in patients with CAD on long-term low-dose aspirin is low, but is accompanied with significant morbidity. With prolonged use of aspirin, UGIB continues to be a problem for those with risk factors and especially in patients with a history of peptic ulcers, in which UGIB tends to occur early after aspirin therapy.Keywords
This publication has 16 references indexed in Scilit:
- Platelet Response to Low-Dose Enteric-Coated Aspirin in Patients With Stable Cardiovascular DiseaseJACC, 2005
- Risk of upper gastrointestinal bleeding in patients taking low‐dose aspirin for the prevention of cardiovascular diseasesAlimentary Pharmacology & Therapeutics, 2002
- Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin UseNew England Journal of Medicine, 2002
- Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low‐dose aspirinAlimentary Pharmacology & Therapeutics, 2002
- Nitrovasodilators, Low-Dose Aspirin, Other Nonsteroidal Antiinflammatory Drugs, and the Risk of Upper Gastrointestinal BleedingNew England Journal of Medicine, 2000
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- The Effect of Chronic Aspirin Use on Duodenal and Gastric Ulcer HospitalizationsJournal of Clinical Gastroenterology, 1990
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Concordant occurrence of gastric and hypertensive diseasesGastroenterology, 1988
- Adaptation of the gastric mucosa to repeated administration of aspirin in the ratDigestive Diseases and Sciences, 1973